Free Access
Issue
Biologie Aujourd'hui
Volume 209, Number 4, 2015
Page(s) 325 - 330
Section Rôle des nutriments dans l’homéostasie énergétique
DOI https://doi.org/10.1051/jbio/2016001
Published online 28 mars 2016
  • Abbott, C.R., Monteiro, M., Small, C.J., Sajedi, A., Smith, K.L., Parkinson, J.R., Ghatei, M.A., and Bloom, S.R. (2005). The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res, 1044, 127-131. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Anderson, J.W., and Bridges, S.R. (1984). Short-chain fatty acid fermentation products of plant fiber affect glucose metabolism of isolated rat hepatocytes. Proc Soc Exp Biol Med, 177, 372–376. [CrossRef] [PubMed] [Google Scholar]
  • Baird, J.P., Grill, H.J. and Kaplan, J.M. (1997). Intake suppression after hepatic portal glucose infusion : all-or-none effect and its temporal threshold. Am J Physiol, 272, R1454-R1460. [PubMed] [Google Scholar]
  • Berthoud, H.R. (2004). Anatomy and function of sensory hepatic nerves. Anat Rec A Discov Mol Cell Evol Biol, 280, 827-835. [CrossRef] [PubMed] [Google Scholar]
  • Breen, D., Yang, C.S., and Lam, T.K. (2011). Gut-brain signaling : how lipids can trigger the gut. Diabetes Metab Res Rev, 27, 113-119. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Capasso, A, Amodeo, P, Balboni, G, Guerrini, R., Lazarus, L.H., Temussi, P.A., and Salvadori, S. (1997). Design of mu selective opioid dipeptide antagonists. FEBS Lett, 417, 141-144. [CrossRef] [PubMed] [Google Scholar]
  • Clore, J.N., Stillman, J., and Sugerman, H. (2000). Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes, 49, 969–974. [CrossRef] [PubMed] [Google Scholar]
  • Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Matsuo, H., Kangawa, K., and Nakazato, M. (2002). The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology, 123, 1120-1128. [CrossRef] [PubMed] [Google Scholar]
  • De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Bäckhed, F., and Mithieux, G. (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell, 156, 84-96. [CrossRef] [PubMed] [Google Scholar]
  • Delaere, F., Magnan, C., and Mithieux, G. (2010). Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes Metab, 36, 257-262. [CrossRef] [PubMed] [Google Scholar]
  • Delaere, F., Duchampt, A., Mounien, L., Seyer, P., Duraffourd, C., Zitoun, C., Thorens, B., and Mithieux, G. (2012). The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. Mol Metab, 2, 47-53. [CrossRef] [PubMed] [Google Scholar]
  • Donohoe, D.R., Garge, N., Zhang, X., Sun, W., O’Connell, T.M., Bunger, M.K., and Bultman, S.J. (2011). The microbiome and butyrate regulate energy metabolism and autophagy in the Mammalian colon. Cell Metab, 13, 517–526. [CrossRef] [PubMed] [Google Scholar]
  • Duraffourd, C., De Vadder, F., Goncalves, D., Delaere, F., Penhoat, A., Brusset, B., Rajas, F., Chassard, D., Duchampt, A., Stefanutti, A., Gautier-Stein, A., and Mithieux, G. (2012). Mu-opioid receptors and dietary protein stimulate a gut-brain neural circuitry limiting food intake. Cell, 150, 377-388. [CrossRef] [PubMed] [Google Scholar]
  • Flint, H.J., Scott, K.P., Louis, P., and Duncan, S.H. (2012). The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol, 9, 577–589. [CrossRef] [PubMed] [Google Scholar]
  • Freeman, S., Bohan, D., Darcel, N., and Raybould, H.E. (2006). Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am J Physiol Gastrointest Liver Physiol, 8, 532-539. [Google Scholar]
  • Gautier-Stein, A., Zitoun, C., Lalli, E., Mithieux, G., and Rajas, F. (2006). Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha. J Biol Chem, 281, 31268–31278. [CrossRef] [PubMed] [Google Scholar]
  • Holzer, P. (2009). Opioid receptors in the gastrointestinal tract. Regul Pept, 155, 11-17. [CrossRef] [PubMed] [Google Scholar]
  • Janssen, P., Van den Berghe, P., Verschueren, S., Lehmann, A., Depoortere, I., and Tack, J. (2011). Review article : the role of gastric motility in the control of food intake. Aliment Pharmacol Ther, 33, 880-894. [CrossRef] [PubMed] [Google Scholar]
  • Langhans, W., Grossmann, F., and Geary, N. (2001). Intrameal hepatic-portal infusion of glucose reduces spontaneous meal size in rats. Physiol Behav, 73, 499-507. [CrossRef] [PubMed] [Google Scholar]
  • Lee, V.H. (2000). Membrane transporters. Eur J Pharmacol Sci, 11 (Suppl 2), S41-S50. [CrossRef] [PubMed] [Google Scholar]
  • Little, T.J., and Feinle-Bisset, C. (2011). Effects of dietary fat on appetite and energy intake in health and obesity-oral and gastrointestinal sensory contributions. Physiol Behav, 104, 613-620. [CrossRef] [PubMed] [Google Scholar]
  • Magnusson, I., Rothman, D.L., Katz, L.D., Shulman, R.G., and Shulman, G.I. (1992). Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest, 90, 1323–1327. [CrossRef] [PubMed] [Google Scholar]
  • Mendeloff, A.I. (1977). Dietary fiber and human health. N Engl J Med, 297, 811–814. [CrossRef] [PubMed] [Google Scholar]
  • Mithieux, G., Misery, P., Magnan, C., Pillot, B., Gautier-Stein, A., Bernard, C., Rajas, F., and Zitoun, C. (2005). Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab, 2, 321-329. [CrossRef] [PubMed] [Google Scholar]
  • Moritoki, H., Takei, M., Kotani, M., Kiso, Y., Ishida, Y., and Endoh, K. (1984).Tripeptides acting on opioid receptors in rat colon. Eur J Pharmacol, 100, 29-39. [CrossRef] [PubMed] [Google Scholar]
  • Penhoat, A., Mutel, E., Amigo-Correig, M., Pillot, B., Stefanutti, A., Rajas, F., and Mithieux, G. (2011). Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis. Physiol Behav, 105, 89-93. [CrossRef] [PubMed] [Google Scholar]
  • Perez-Tilve, D., D’Alessio, D.A. and Tschop, M.H. (2008). A sweet spot for the bariatric surgeon. Cell Metab, 8, 177-179. [CrossRef] [PubMed] [Google Scholar]
  • Pillot, B., Duraffourd, C., Bégeot, M., Joly, A., Luquet, S., Houberdon, I., Naville, D., Vigier, M., Gautier-Stein, A., Magnan, C., and Mithieux, G. (2011). Role of hypothalamic melanocortin system in adaptation of food intake to food protein increase in mice. Plos One, 6, e19107. [CrossRef] [PubMed] [Google Scholar]
  • Ray, T.K., Mansell, K.M., Knight, L.C., Malmud, L.S., Owen, O.E., and Boden, G. (1983). Long-term effects of dietary fiber on glucose tolerance and gastric emptying in noninsulin-dependent diabetic patients. Am J Clin Nutr, 37, 376–381. [PubMed] [Google Scholar]
  • Sala, P.C., Torrinhas, R.S., Heymsfield, S.B. and Waitzberg, D.L. (2012). Type 2 diabetes mellitus : a possible surgically reversible intestinal dysfunction. Obes Surg, 22, 167-176. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Schiller, P. (2002). Opioid dipeptide derivatives with a mixed μ antagonist/antagonist, partial μ agonist/ antagonist or μ agonist/partial agonist profile. Am Pept Symp, 6, 229-270. [CrossRef] [Google Scholar]
  • Smith, G.P., Jerome, C., Cushin, B.J., Eterno, R., and Simansky, K.J. (1981). Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science, 213, 1036-1037. [CrossRef] [PubMed] [Google Scholar]
  • Thaler, J.P. and Cummings, D.E. (2009). Minireview : Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology, 150, 2518-2525. [CrossRef] [PubMed] [Google Scholar]
  • Tordoff, M.G. and Friedman, M.I. (1986). Hepatic portal glucose infusions decrease food intake and increase food preference. Am J Physiol, 251, R192-R196. [PubMed] [Google Scholar]
  • Troy, S., Soty, M., Ribeiro, L., Laval, L., Migrenne, S., Fioramonti, X., Pillot, B., Fauveau, V., Aubert, R., Viollet, B., Foretz, M., Leclerc, J., Duchampt, A., Zitoun, C., Thorens, B., Magnan, C., Mithieux, G., and Andreelli, F. (2008). Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab, 8, 201-211. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Vahl, T.P., Tauchi, M., Durler, T.S., Elfers, E.E., Fernandes, T.M., Bitner, R.D., Ellis, K.S., Woods, S.C., Seeley, R.J., Herman, J.P., and D’Alessio, D.A. (2007). Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology, 148, 4965-4973. [CrossRef] [PubMed] [Google Scholar]
  • Zioudrou, C., Streaty, R.A. and Klee, W.A. (1979). Opioid peptides derived from food proteins. The exorphins. J Biol Chem, 254, 2446-1449. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.